Pharma

AbbVie stock (ABBV): FDA clears new Venclexta-Calquence CLL combo — what to watch Monday
···

AbbVie-Aktie (ABBV): FDA genehmigt neue Venclexta-Calquence-Kombination für CLL – das ist am Montag zu beachten

Die US-Arzneimittelbehörde FDA hat eine neue Erstlinien-Kombination aus AstraZenecas Calquence und AbbVies Venclexta für chronische lymphatische Leukämie zugelassen. In der AMPLIFY-Studie verlängerte das Regime das progressionsfreie Überleben gegenüber der Standardtherapie. AbbVie-Aktien schlossen am Freitag bei 224,81 Dollar, ein Plus von 0,21 Prozent.
Februar 23, 2026

Stock Market Today

  • UK Shares Rise as BP Chair Steps Down Amid Governance Issues
    May 26, 2026, 12:37 PM EDT. UK equities edged higher with the FTSE 100 up 0.24% on Tuesday following the Spring Bank Holiday. Oil giant BP fell 4.03% after announcing the immediate resignation of Chair Albert Manifold due to board concerns over governance and conduct. Metlen Energy & Metals surged 6.46% after the European Commission approved its joint venture with Greece's Public Power Corp. Kingfisher shares rose 1.71%, buoyed by steady sales and confirmed profit guidance for Q1. The British Retail Consortium reported shop price inflation climbed to 1.2% in May, fueled by rising shipping and material costs amid Middle East tensions. Retailers warn that ongoing cost pressures could push prices higher, urging government action to reduce business expenses. Key UK economic data this week includes April's car production and May housing prices.